Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

CytoDyn PE Ratio 2010-2025 | CYDY

Current and historical p/e ratio for CytoDyn (CYDY) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. CytoDyn PE ratio as of May 01, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
  
CytoDyn PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-04-30 0.27 0.00
2025-02-28 0.31 0 0.00
2024-11-30 0.11 $-0.01 0.00
2024-08-31 0.15 $-0.02 0.00
2024-05-31 0.16 $-0.05 0.00
2024-02-29 0.26 $-0.05 0.00
2023-11-30 0.17 $-0.06 0.00
2023-08-31 0.21 $-0.08 0.00
2023-05-31 0.26 $-0.10 0.00
2023-02-28 0.32 $-0.08 0.00
2022-11-30 0.36 $-0.11 0.00
2022-08-31 0.52 $-0.08 0.00
2022-05-31 0.32 $-0.10 0.00
2022-02-28 0.51 $-0.18 0.00
2021-11-30 1.25 $-0.21 0.00
2021-08-31 1.38 $-0.27 0.00
2021-05-31 1.90 $-0.28 0.00
2021-02-28 4.52 $-0.33 0.00
2020-11-30 2.67 $-0.33 0.00
2020-08-31 3.36 $-0.31 0.00
2020-05-31 2.96 $-0.29 0.00
2020-02-29 1.05 $-0.21 0.00
2019-11-30 0.28 $-0.17 0.00
2019-08-31 0.40 $-0.19 0.00
2019-05-31 0.39 $-0.22 0.00
2019-02-28 0.50 $-0.21 0.00
2018-11-30 0.58 $-0.27 0.00
2018-08-31 0.69 $-0.28 0.00
2018-05-31 0.49 $-0.29 0.00
2018-02-28 0.79 $-0.30 0.00
2017-11-30 0.59 $-0.26 0.00
2017-08-31 0.68 $-0.23 0.00
2017-05-31 0.60 $-0.19 0.00
2017-02-28 0.71 $-0.19 0.00
2016-11-30 0.67 $-0.18 0.00
2016-08-31 1.04 $-0.20 0.00
2016-05-31 0.99 $-0.28 0.00
2016-02-29 0.90 $-0.47 0.00
2015-11-30 0.86 $-0.47 0.00
2015-08-31 0.78 $-0.50 0.00
2015-05-31 0.99 $-0.44 0.00
2015-02-28 0.84 $-0.25 0.00
2014-11-30 1.24 $-0.26 0.00
2014-08-31 0.85 $-0.25 0.00
2014-05-31 0.66 $-0.27 0.00
2014-02-28 0.88 $-0.30 0.00
2013-11-30 1.25 $-0.32 0.00
2013-08-31 0.90 $-0.30 0.00
2013-05-31 0.80 $-0.32 0.00
2013-02-28 1.00 $-0.37 0.00
2012-11-30 1.60 $-0.35 0.00
2012-08-31 0.77 $-0.36 0.00
2012-05-31 1.50 $-0.31 0.00
2012-02-29 2.65 $-0.23 0.00
2011-11-30 2.75 $-0.22 0.00
2011-08-31 1.82 $-0.20 0.00
2011-05-31 2.74 $-0.18 0.00
2011-02-28 1.80 $-0.55 0.00
2010-11-30 1.15 $-0.54 0.00
2010-08-31 1.40 $-0.53 0.00
2010-05-31 1.50 $-0.52 0.00
2010-02-28 2.00 $-0.10 0.00
2009-11-30 1.90 $-0.08 0.00
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.368B $0.000B
CytoDyn is a biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment and prevention of HIV infection. The Company has one of the leading monoclonal antibodies under development for HIV infection, PRO 140, which has completed Phase 2 clinical trials with demonstrated antiviral activity in humans and is currently in Phase 3 development. PRO 140 blocks the HIV co-receptor CCR5 on T cells, which prevents viral entry. Clinical trial results thus far indicate that PRO 140 does not negatively affect the normal immune functions that are mediated by CCR5. Results from seven Phase 1 and Phase 2 human clinical trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV. A recent Phase 2b clinical trial demonstrated that PRO 140 can prevent viral escape in patients during several months of interruption from conventional drug therapy.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) JP $95.374B 35.78
Zoetis (ZTS) US $69.448B 26.29
Daiichi Sankyo, - (DSNKY) JP $48.414B 24.63
Takeda Pharmaceutical (TAK) JP $47.824B 10.59
Sandoz Group AG (SDZNY) CH $18.977B 0.00
Summit Therapeutics (SMMT) US $18.321B 0.00
Merck (MKKGY) DE $17.848B 14.77
Shionogi (SGIOY) JP $14.096B 14.12
United Therapeutics (UTHR) US $13.255B 11.73
Neurocrine Biosciences (NBIX) US $10.546B 32.40
IPSEN (IPSEY) FR $9.907B 0.00
Orion OYJ (ORINY) FI $9.027B 24.41
Corcept Therapeutics (CORT) US $7.580B 57.65
Madrigal Pharmaceuticals (MDGL) US $7.276B 0.00
Stevanato Group S.p.A (STVN) IT $6.281B 39.88
Ono Pharmaceutical (OPHLF) JP $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) GB $5.813B 0.00
Ionis Pharmaceuticals (IONS) US $5.047B 0.00
Grifols, S.A (GRFS) ES $4.827B 0.00
Soleno Therapeutics (SLNO) US $3.744B 0.00
Crinetics Pharmaceuticals (CRNX) US $3.138B 0.00
Catalyst Pharmaceuticals (CPRX) US $2.960B 12.02
AMNEAL PHARMACEUTICALS, INC (AMRX) US $2.399B 14.89
Hypermarcas (HYPMY) BR $2.350B 15.46
Recursion Pharmaceuticals (RXRX) US $2.211B 0.00
NewAmsterdam Pharma (NAMS) NL $2.200B 0.00
BioCryst Pharmaceuticals (BCRX) US $1.822B 0.00
Centessa Pharmaceuticals (CNTA) GB $1.798B 0.00
Indivior (INDV) US $1.593B 6.75
Guardian Pharmacy Services (GRDN) US $1.568B 0.00
Evotec AG (EVO) DE $1.502B 0.00
ARS Pharmaceuticals (SPRY) US $1.391B 177.00
Dyne Therapeutics (DYN) US $1.362B 0.00
Ocular Therapeutix (OCUL) US $1.359B 0.00
Ardelyx (ARDX) US $1.304B 0.00
Aurinia Pharmaceuticals Inc (AUPH) CA $1.121B 45.56
Enliven Therapeutics (ELVN) US $0.974B 0.00
Harrow (HROW) US $0.917B 0.00
Collegium Pharmaceutical (COLL) US $0.869B 4.62
Avadel Pharmaceuticals (AVDL) IE $0.832B 0.00
Xencor (XNCR) US $0.773B 0.00
Cronos Group (CRON) CA $0.721B 0.00
AleAnna (ANNA) US $0.718B 0.00
Xeris Biopharma Holdings (XERS) US $0.701B 0.00
KalVista Pharmaceuticals (KALV) US $0.676B 0.00
Organogenesis (ORGO) US $0.629B 0.00
Akebia Therapeutics (AKBA) US $0.626B 0.00
Bioventus (BVS) US $0.595B 15.45
Savara (SVRA) US $0.563B 0.00
Relay Therapeutics (RLAY) US $0.561B 0.00
USANA Health Sciences (USNA) US $0.529B 11.35
Regulus Therapeutics (RGLS) US $0.520B 0.00
Theravance Biopharma (TBPH) KY $0.520B 0.00
Verve Therapeutics (VERV) US $0.490B 0.00
Tourmaline Bio (TRML) US $0.458B 0.00
Amylyx Pharmaceuticals (AMLX) US $0.458B 0.00
Elite Pharmaceuticals (ELTP) US $0.454B 0.00
Zevra Therapeutics (ZVRA) US $0.418B 0.00
Altimmune (ALT) US $0.398B 0.00
Siga Technologies (SIGA) US $0.388B 6.62
Oruka Therapeutics (ORKA) US $0.378B 0.00
Heron Therapeutics (HRTX) US $0.358B 0.00
Rigel Pharmaceuticals (RIGL) US $0.334B 19.92
Aquestive Therapeutics (AQST) US $0.298B 0.00
ProKidney (PROK) US $0.250B 0.00
Avita Medical (RCEL) US $0.247B 0.00
Nature's Sunshine Products (NATR) US $0.227B 26.70
Wellgistics Health (WGRX) US $0.223B 0.00
OmniAb (OABI) US $0.216B 0.00
Esperion Therapeutics (ESPR) US $0.195B 24.60
MediWound (MDWD) IL $0.186B 0.00
Larimar Therapeutics (LRMR) US $0.183B 0.00
Korro Bio (KRRO) US $0.173B 0.00
Inhibikase Therapeutics (IKT) US $0.167B 0.00
Aldeyra Therapeutics (ALDX) US $0.162B 0.00
4D Molecular Therapeutics (FDMT) US $0.159B 0.00
Journey Medical (DERM) US $0.159B 0.00
Lexeo Therapeutics (LXEO) US $0.156B 0.00
Nanobiotix S.A (NBTX) FR $0.156B 0.00
Procaps Group, S.A (PROCF) LU $0.156B 0.00
Aclaris Therapeutics (ACRS) US $0.149B 0.00
Ironwood Pharmaceuticals (IRWD) US $0.148B 45.60
Nektar Therapeutics (NKTR) US $0.145B 0.00
Profound Medical (PROF) CA $0.145B 0.00
Lyell Immunopharma (LYEL) US $0.139B 0.00
Protara Therapeutics (TARA) US $0.133B 0.00
Enanta Pharmaceuticals (ENTA) US $0.129B 0.00
Innate Pharma SA (IPHYF) FR $0.122B 0.00
Tonix Pharmaceuticals Holding (TNXP) US $0.116B 0.00
VAXART, INC (VXRT) US $0.098B 0.00
OptiNose (OPTN) US $0.095B 0.00
Cardiol Therapeutics (CRDL) CA $0.093B 0.00
Corbus Pharmaceuticals Holdings (CRBP) US $0.092B 0.00
Champions Oncology (CSBR) US $0.088B 14.50
Achieve Life Sciences (ACHV) CA $0.085B 0.00
Arch Biopartners (ACHFF) CA $0.083B 0.00
Galectin Therapeutics (GALT) US $0.082B 0.00
ESSA Pharma (EPIX) CA $0.079B 0.00
Cassava Sciences (SAVA) US $0.078B 0.00
Unicycive Therapeutics (UNCY) US $0.078B 0.00
Context Therapeutics (CNTX) US $0.077B 0.00
Telomir Pharmaceuticals (TELO) US $0.075B 0.00
Dominari Holdings (DOMH) US $0.075B 0.00
Nutriband (NTRB) US $0.070B 0.00
Pyxis Oncology (PYXS) US $0.068B 0.00
Cumberland Pharmaceuticals (CPIX) US $0.067B 0.00
Inotiv (NOTV) US $0.067B 0.00
Gain Therapeutics (GANX) US $0.064B 0.00
Assertio Holdings (ASRT) US $0.062B 0.00
Fractyl Health (GUTS) US $0.062B 0.00
Vivani Medical (VANI) US $0.062B 0.00
Allergy Therapeutics (AGYTF) GB $0.059B 0.00
Karyopharm Therapeutics (KPTI) US $0.058B 0.00
Metagenomi (MGX) US $0.056B 0.00
ElectroCore (ECOR) US $0.054B 0.00
Avalo Therapeutics (AVTX) US $0.054B 0.00
PMV Pharmaceuticals (PMVP) US $0.052B 0.00
Century Therapeutics (IPSC) US $0.048B 0.00
Mural Oncology (MURA) IE $0.045B 0.00
Verrica Pharmaceuticals (VRCA) US $0.043B 0.00
Acrivon Therapeutics (ACRV) US $0.042B 0.00
Reviva Pharmaceuticals Holdings (RVPH) US $0.041B 0.00
Prelude Therapeutics (PRLD) US $0.040B 0.00
Rafael Holdings (RFL) US $0.040B 0.00
Iterum Therapeutics (ITRM) IE $0.039B 0.00
SCYNEXIS (SCYX) US $0.038B 0.00
NRx Pharmaceuticals (NRXP) US $0.036B 0.00
Surrozen (SRZN) US $0.034B 0.00
FibroGen (FGEN) US $0.034B 0.00
PolyPid (PYPD) IL $0.029B 0.00
Tempest Therapeutics (TPST) US $0.025B 0.00
CASI Pharmaceuticals (CASI) CN $0.024B 0.00
Enlivex Therapeutics (ENLV) IL $0.022B 0.00
Jupiter Neurosciences (JUNS) US $0.021B 0.00
VYNE Therapeutics (VYNE) US $0.020B 0.00
Mannatech (MTEX) US $0.020B 7.86
Lipocine (LPCN) US $0.019B 0.00
Natural Alternatives (NAII) US $0.019B 0.00
DURECT (DRRX) US $0.018B 0.00
GlycoMimetics (GLYC) US $0.017B 0.00
TherapeuticsMD (TXMD) US $0.016B 0.00
Vivos Therapeutics (VVOS) US $0.016B 0.00
BioVie (BIVI) US $0.016B 0.00
MEI Pharma (MEIP) US $0.014B 0.00
ProPhase Labs (PRPH) US $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) US $0.013B 0.00
TransCode Therapeutics (RNAZ) US $0.013B 0.00
Cosmos Health (COSM) US $0.013B 0.00
Scienture Holdings (SCNX) US $0.012B 0.00
Minerva Neurosciences (NERV) US $0.012B 8.79
Relmada Therapeutics (RLMD) US $0.012B 0.00
BioLineRx (BLRX) IL $0.011B 0.00
Plus Therapeutics (PSTV) US $0.011B 0.00
Ernexa Therapeutics (ERNA) US $0.010B 0.00
Kiora Pharmaceuticals (KPRX) US $0.010B 3.16
Biomerica (BMRA) US $0.009B 0.00
Addex Therapeutics (ADXN) CH $0.009B 0.00
Phio Pharmaceuticals (PHIO) US $0.009B 0.00
Talphera (TLPH) US $0.009B 0.00
Carisma Therapeutics (CARM) US $0.008B 0.00
Ainos (AIMD) US $0.008B 0.00
XTL Biopharmaceuticals (XTLB) IL $0.008B 0.00
Mangoceuticals (MGRX) US $0.008B 0.00
Nuvilex (PMCB) US $0.008B 0.00
Jaguar Animal Health (JAGX) US $0.008B 0.00
Indaptus Therapeutics (INDP) US $0.008B 0.00
Traws Pharma (TRAW) US $0.008B 0.00
Lyra Therapeutics (LYRA) US $0.007B 0.00
Citius Pharmaceuticals (CTXR) US $0.007B 0.00
Conduit Pharmaceuticals (CDT) US $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) US $0.006B 0.00
NLS Pharmaceutics (NLSP) CH $0.005B 0.00
Klotho Neurosciences (KLTO) US $0.005B 0.00
Aptorum Group (APM) GB $0.005B 0.00
CERo Therapeutics Holdings (CERO) US $0.005B 0.00
Clearmind Medicine (CMND) CA $0.004B 0.00
Xenetic Biosciences (XBIO) US $0.004B 0.00
XORTX Therapeutics (XRTX) CA $0.004B 0.00
Quoin Pharmaceuticals (QNRX) US $0.004B 0.00
Redhill Biopharma (RDHL) IL $0.004B 0.00
InMed Pharmaceuticals (INM) CA $0.004B 0.00
Alaunos Therapeutics (TCRT) US $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) US $0.004B 0.00
SciSparc (SPRC) IL $0.003B 0.00
Qualigen Therapeutics (QLGN) US $0.003B 0.00
Incannex Healthcare (IXHL) AU $0.002B 0.00
Galmed Pharmaceuticals (GLMD) IL $0.002B 0.00
TNF Pharmaceuticals (TNFA) US $0.002B 0.00
PainReform (PRFX) IL $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) US $0.002B 0.00
China SXT Pharmaceuticals (SXTC) CN $0.002B 0.00
SHINECO (SISI) CN $0.002B 0.00
Salarius Pharmaceuticals (SLRX) US $0.001B 0.00
Heatwurx (PCSA) US $0.001B 0.00
Petros Pharmaceuticals (PTPI) US $0.001B 0.00
Universe Pharmaceuticals INC (UPC) CN $0.000B 0.00
Aditxt (ADTX) US $0.000B 0.00
4D Pharma (LBPS) GB $0.000B 0.00
Patheon (PTHN) NL $0.000B 0.00
RVL Pharmaceuticals (RVLP) US $0.000B 0.00
Silence Therapeutics (SLN) GB $0.000B 0.00